venBio Partners LLC Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$216.3B

Holdings

6

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
PHVSPHARVARIS N V
4,639,304$128.7B59.53%
2
ALMSALUMIS INC
4,619,803$45.1B20.85%
3
HRMYHARMONY BIOSCIENCES HLDGS IN
489,194$18.3B8.46%
4
ALXOALX ONCOLOGY HLDGS INC
9,699,925$11.0B5.07%
5
LYELLYELL IMMUNOPHARMA INC
337,697$10.4B4.81%
6
ARTVARTIVA BIOTHERAPEUTICS INC
648,507$2.8B1.29%